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ABSTRACT: Recently, several indications have been found that suggest a preferential interaction between
cholesterol and tryptophan residues located near the membrane-water interface. The aim of this study
was to investigate by direct methods how tryptophan and cholesterol interact with each other and what
the possible consequences are for membrane organization. For this purpose, we used cholesterol-containing
model membranes of dimyristoylphosphatidylcholine (DMPC) in which a transmembrane model peptide
with flanking tryptophans [acetyl-GWW(LA)8LWWA-amide], called WALP23, was incorporated to mimic
interfacial tryptophans of membrane proteins. These model systems were studied with two complementary
methods. (1) Steady-state and time-resolved Fo¨rster resonance energy transfer (FRET) experiments
employing the fluorescent cholesterol analogue dehydroergosterol (DHE) in combination with a competition
experiment with cholesterol were used to obtain information about the distribution of cholesterol in the
bilayer in the presence of WALP23. The results were consistent with a random distribution of cholesterol
which indicates that cholesterol and interfacial tryptophans are not preferentially located next to each
other in these bilayer systems. (2) Solid-state 2H NMR experiments employing either deuterated cholesterol
or indole ring-deuterated WALP23 peptides were performed to study the orientation and dynamics of
both molecules. The results showed that the quadrupolar splittings of labeled cholesterol were not affected
by an interaction with tryptophan-flanked peptides and, vice versa, that the quadrupolar splittings of labeled
indole rings in WALP23 are not significantly influenced by addition of cholesterol to the bilayer. Therefore,
both NMR and fluorescence spectroscopy results independently show that, at least in the model systems
studied here, there is no evidence for a preferential interaction between cholesterol and tryptophans located
at the bilayer interface.
Biological membranes are composed of a variety of
different lipids and contain a huge diversity of membrane
proteins. They are very heterogeneous systems and often
include membrane microdomains that can have compositions
different from that of the bulk membrane and that are
important for some membrane proteins to fulfill their func-
tions (1). Often the formation of these membrane micro-
domains involves local enrichment of cholesterol (2, 3).
Cholesterol can be found in membranes of eukaryotic
organisms and is a major constituent in some types of
membranes (4). It is thought to have a dual function in the
membrane (5). On one hand, it has an ordering effect on
acyl chains of surrounding (phospho)lipids which results in
a more condensed bilayer. Membrane domains with an
increased cholesterol content, also referred to as lipid rafts,
therefore have an increased bilayer thickness. On the other
hand, cholesterol introduces negative membrane curvature
and is able to fill voids in the bilayer due to its bulky body.
The presence of cholesterol thus affects several membrane
properties which can also influence the function and distribu-
tion of membrane proteins.
Membrane proteins perform many essential functions in
the cell such as transport, signaling, catalysis, and transduc-
tion of energy. The transmembrane domains of these proteins
are hydrophobic and frequently include aromatic residues
such as tryptophan and tyrosine located at the lipid-water
interface (6, 7). In particular, these interfacial tryptophans
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are believed to anchor transmembrane domains of membrane
proteins in the bilayer and to help them to adopt correct
positioning needed for proper functioning (8, 9). Tryptophans
at the membrane interface are also thought to have an
important role in folding and assembly of transmembrane
complexes of membrane proteins (7).
The indole ring makes tryptophan the bulkiest amino acid
among all 20 amino acids naturally occurring in proteins and
allows amphipathic interactions, including imino group
hydrogen bonding, specific dipolar interactions, cation-ð
interactions, and hydrophobic interactions (7, 10, 11). The
special character of the indole ring provides the potential to
interact with a variety of molecules. The rigid indole ring
of tryptophan is often found stacking with other rigid ring
structures than found in nucleic acids or other amino acids,
including phenylalanine and tyrosine.
Cholesterol also has a complex rigid ring structure which
could favorably interact with the indole ring of tryptophans.
If such an interaction occurs and if it is sufficiently favorable,
it could lead to a preferential interaction between cholesterol
and tryptophans located at the bilayer interface. Indeed,
several indications have been found for such an interaction.
In a study by Gasset et al. (12), the authors proposed the
formation of a complex between cholesterol and the tryp-
tophan-rich gramicidin A driven by hydrophobic interactions.
Carozzi et al. (13) found that a cysteine to tryptophan
mutation in the membrane protein caveolin-3 affects the
distribution of cholesterol in the membrane. This naturally
occurring C71W mutation was observed to increase the
affinity of caveolin-3 for cholesterol and thereby prevent the
release of cholesterol from caveolae to noncaveolar mem-
brane domains. In another study, Santiago et al. (14) found
that a cysteine to tryptophan mutation alters the function of
the nicotinic acetylcholine receptor AChR. This R C418W
mutation which is located in a lipid-exposed transmembrane
segment dramatically enhanced the response of the receptor
to cholesterol modulation. Finally, Van Duyl et al. (5)
observed a synergistic effect between cholesterol and tryp-
tophan-flanked transmembrane peptides in lipid phase be-
havior. They found that model membranes composed of
unsaturated phospholipids and cholesterol form an isotropic
phase upon incorporation of tryptophan-flanked peptides.
This was not observed for model peptides in which the
flanking tryptophans had been replaced with lysines or
histidines, and these results led the authors to propose a
preferential interaction between cholesterol and interfacial
tryptophans.
In spite of these indications for a preferential interaction
between cholesterol and tryptophans, there is little known
about the interaction and the possible consequences for
membrane organization. Here, we investigated this issue by
employing tryptophan-flanked model peptides which were
incorporated into bilayers of phospholipids containing vary-
ing amounts of cholesterol. These peptides, called WALP
peptides, consist of a stretch of alternating leucines and
alanines flanked on both sides by a pair of tryptophans. These
transmembrane peptides have been designed as well-defined
models to gain insight into basic principles of membrane
organization and have been studied extensively throughout
the past decade (9, 15-17). They have often been used to
mimic transmembrane segments of membrane proteins (16)
and readily integrate into bilayers under formation of stable
transmembrane R-helices.
To study the interaction between cholesterol and the
interfacial tryptophans of WALP peptides, we used a 2-fold
approach employing fluorescence spectroscopy and NMR1
spectroscopy. Fluorescence experiments using Fo¨rster reso-
nance energy transfer (FRET) between tryptophan and the
fluorescent cholesterol analogue dehydroergosterol (DHE)
were used to obtain information about the distribution of
cholesterol in the bilayer with respect to the peptides. Solid-
state 2H NMR measurements using either deuterated cho-
lesterol or tryptophan-deuterated WALP peptides were
performed to observe possible changes in the motion and
orientation of cholesterol and tryptophan. The results indicate
that cholesterol remains homogeneously distributed in the
bilayer in the presence of tryptophan-flanked peptides and
that the dynamics and orientation of neither cholesterol nor
tryptophans located at the bilayer interface are influenced
by the presence of the other molecule.
MATERIALS AND METHODS
Materials. Unlabeled WALP23, KALP23, WLP23, and
KLP23 peptides (for amino acid sequences, see Table 1) were
synthesized using Fmoc/tBu solid-phase synthesis as de-
scribed elsewhere for related KALP peptides (18). Deuterium-
labeled L-tryptophan (indole-d5, 98%) was purchased from
Cambridge Isotopes Laboratories Inc. (Andover, MA), and
Fmoc (9-fluorenylmethyloxycarbonyl) was used to protect
its amino functionality as described by Ten Kortenaar et al.
(19) before being used in the peptide synthesis. The
deuterium-labeled WALP23 peptides were synthesized ac-
cording to the procedure described in ref 20 to prevent
exchange of deuterons located at the indole ring against
hydrogens in the presence of trifluoroacetic acid (TFA) (21).
Due to the use of ethanolamine as a cleavage agent, the
C-terminus of the deuterium-labeled WALP23 peptide is
capped by ethanolamine instead of an amide. Indole ring-
1 Abbreviations: DHE, dehydroergosterol; DMPC, dimyristoylphos-
phatidylcholine; FRET, Fo¨rster resonance energy transfer; KALP23 and
KLP23, lysine-flanked R-helical model peptides; LUV, large unilamellar
vesicle; NMR, nuclear magnetic resonance; TFE, trifluoroethanol;
WALP23 and WLP23, tryptophan-flanked R-helical peptides.
Table 1: Amino Acid Sequences of the Model Peptides
peptide amino acid sequence
WALP23 acetyl-GWWLALALALALALALALALWWA-amide
KALP23 acetyl-GKKLALALALALALALALALKKA-amide
WLP23 acetyl-GWWLLLLLLLLLLLLLLLLLWWA-amide
KLP23 acetyl-GKKLLLLLLLLLLLLLLLLLKKA-amide
WALP23-d5-Trp2 acetyl-GWWLALALALALALALALALWWA-ethanolaminea
WALP23-d5-Trp3 acetyl-GWWLALALALALALALALALWWA-ethanolaminea
a Bold letters indicate positions labeled with indole-deuterated d5-Trp.
Cholesterol-Tryptophan Interactions Biochemistry, Vol. 47, No. 8, 2008 2639
deuterated tryptophans were introduced at position 2 or 3 of
the WALP23 peptide. The identity of the synthesized
peptides was verified by mass spectrometry, and the purity
was analyzed by HPLC using a C4 reverse phase HPLC
column with an aqueous phosphorous acid/triethylamine
buffer at pH 2.25, according to procedures described in ref
22. The purity of peptides used in this study was generally
better than 95%.
Cholesterol and 1,2-dimyristoyl-sn-glycero-3-phospho-
choline (DMPC) were purchased from Avanti Polar Lipids
Inc. (Alabaster, AL) and used without further purification.
â-(d6-2,2,3,4,4,6)Cholesterol was purchased from Medical
Isotopes Inc. (Pelham, NH). 2,2,2-Trifluoroethanol (TFE)
was obtained from Merck (Darmstadt, Germany). Ergosta-
5,7,9(11),22-tetraen-3â-ol (DHE, >96%) was purchased from
Sigma Aldrich. All lipids were used without further purifica-
tion. All other chemicals used were analytical grade.
Deuterium-depleted water for NMR samples was obtained
from Cambridge Isotope Laboratories, Inc. All other water
used during sample preparation was deionized and purified
with a Milli-Q Gradient Water purification system from
Millipore Corp. (Billerica, MA).
Methods. (i) Fluorescence Spectroscopy. Stock solutions
of ca. 20 mM DMPC in chloroform were prepared, and the
lipid concentration was determined by a phosphorus assay
(23). Stock solutions of WALP23 and DHE were prepared
with a concentration of ca. 200 íM in TFE and MeOH,
respectively. The concentration of WALP23 and DHE was
determined by absorption spectroscopy using extinction
coefficients of 22 400 M-1 cm-1 at 280 nm for WALP23
(24) and 10 500 M-1 cm-1 at 324 nm for DHE (25).
Cholesterol stock solutions were prepared by weight with a
concentration of 5 mM in chloroform.
All fluorescence experiments were performed with a
constant peptide/phospholipid molar ratio of 1/200 and a final
peptide concentration of 5 íM. First, appropriate amounts
of peptide and phospholipid were mixed in solution and
distributed over a number of tubes. Then varying amounts
of DHE (0-8 mol %) were added to the tubes. For
competition experiments, additionally equimolar amounts of
cholesterol were added. After thorough mixing, the organic
solvents were evaporated under a nitrogen flow and were
further removed under vacuum overnight (ca. 1  10-2
mbar). Then the samples were hydrated with buffer [25 mM
HEPES and 100 mM NaCl (pH 7.0)] and incubated for 30
min. Large unilamellar vesicles (LUVs) were produced by
first freeze-thawing the samples at least 10 times and
subsequent extrusion through inorganic membrane filters with
a pore size of 200 nm (Anotop 10; Whatman International
Ltd., Maidstone, England).
For steady-state fluorescence measurements, the samples
(1.2 mL) were directly after preparation transferred to a 10
mm quartz cuvette. All measurements were performed using
a SLM-Aminco SPF-500 C fluorimeter (Jobin Yvon, Edison,
NJ) and were carried out at 30 °C to ensure that the lipid
bilayers are in the fluid phase. The samples were allowed to
equilibrate in the fluorimeter for at least 5 min under
continuous stirring before the measurements. The tryptophans
of WALP23 were excited at 280 nm, and emission from
tryptophan and DHE was recorded from 300 to 525 nm using
a bandwidth of 5 nm for both the excitation and emission
channel. All emission spectra were corrected for instrument
specific deviations using a standard emission spectrum of
L-tryptophan (26). Samples without peptide and DHE were
used to correct for light scattering of the vesicle suspensions.
Fluorescence decay measurements were carried out on a
time-correlated single-photon timing system which is de-
scribed elsewhere (27, 28). All time-resolved fluorescence
measurements were performed at 30 °C. For the FRET
experiments, the donor (Trp in WALP23) was excited at 290
nm to minimize absorption of the acceptor (DHE). Tryp-
tophan emission was collected at 330 nm using the magic
angle relative to the vertically polarized excitation beam, and
to avoid scattered excitation, a cutoff filter was added to the
monochromator. The collection bandwidth was set to 20 nm
to prevent acceptor emission from reaching the detector. The
fluorescence decays were obtained with an accumulation of
20 000 counts on the peak channel and time scales ranging
from 22 ps/channel for donor only to 12 ps/channel for high
acceptor concentrations.
(ii) Analysis of Fluorescence Data. Data analysis was
carried out using a nonlinear, least-squares iterative convolu-
tion method based on the algorithm of Marquardt (29). The
decay curves obtained for different acceptor concentrations
were analyzed using a global analysis approach with linkage
of lifetimes and ratios of preexponential factors (27). The
quality of the fit was judged from ł2 values of the individual
experiments, the global ł2 value (łG2), and weighted residuals
and autocorrelation plots.
The critical distance for FRET, the Fo¨rster distance (R0),
was calculated by
where  is the orientation factor for dipole-dipole coupling
of the donor and acceptor, …D is the quantum yield of the
donor in the absence of the acceptor, n is the refractive index
of the medium, ì is the wavelength expressed in nanometers,
I(ì) is the normalized emission spectrum of the donor, and
(ì) is the molar absorption spectrum of the acceptor in M-1
cm-1 (30). The resulting Fo¨rster distance has units of
angstroms. An n ) 1.4 refractive index was used for the
bilayer interface (30, 31) which is an average value between
n ) 1.5 for the bilayer interior (32) and n ) 1.33 for an
aqueous environment. For the orientation factor 2, a value
of 2/3 was used which represents the dynamic isotropic limit;
i.e., the donor and acceptor undergo fast reorientation during
the lifetime of the excited state of the donor (31, 33). This
value is commonly used for FRET experiments performed
in bilayers (27, 34).
For FRET within one leaflet of the bilayer, the decay of
donor fluorescence in the presence of an acceptor for
unlinked and randomly distributed donor and acceptor was
derived in ref 35
where n is the surface density of acceptors, Re is the radius
of exclusion of acceptors around the donor, and the average
lifetime 〈ô〉 ) ∑iRiôi2/∑iRiôi. For the calculations of the FRET
R0 ) 0.2108[2n-4…D s0∞ì4I(ì)(ì) dì]1/6 (1)
Fcis(t) ) exp(-ðR02nç[23,(R0Re)6( t〈ô〉)]( t〈ô〉)1/3 +
ðRe
2
n{1 - exp[-(R0Re)6( t〈ô〉)]}) (2)
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efficiency between the tryptophans of WALP23 and DHE
in DMPC bilayers, the radius of exclusion (Re) was estimated
to be 7.5 Å, being the sum of the radii of tryptophan and
DHE calculated from the square root over the area of the
molecules in the bilayer. The incomplete Gamma function
ç is defined as ç[x,y] ) s0y zx-1 exp(-z) dz.
For FRET to the opposing bilayer leaflet, the decay of
donor fluorescence was derived in ref 31
where w is the interplanar distance between the donor and
acceptor which was considered to be 23 Å on the basis of
molecular models.
The decay of donor fluorescence in the presence of
acceptor molecules in both leaflets is then described by
Finally, the FRET efficiency is calculated by numerical
integration of
where iD(t) ) ∑iRi exp[-(t/ôDi)] describes the fluorescence
decay of the donor in the absence of acceptor and 〈ô〉D )
∑iRiôi corresponds to the donor lifetime weighted by quantum
yield.
(iii) NMR Spectroscopy. Phospholipid and (deuterated)
cholesterol stock solutions were prepared as described above.
For NMR experiments employing deuterated cholesterol,
typically 2 ímol of deuterated cholesterol and 100 ímol of
phospholipids were used per sample. The lipids were mixed
in solution, and organic solvents were removed as described
above. Deuterium-depleted buffer was prepared by lyo-
philization of a small amount of buffer [25 mM HEPES and
100 mM NaCl (pH 7.0)] prepared with Milli-Q water which
was rehydrated with the same amount of deuterium-depleted
water. The samples were first hydrated with Milli-Q water
(1 mL) and lyophilized. Then the powder was transferred to
the smaller NMR tubes and hydrated using 100 íL of
deuterium-depleted buffer. The NMR tubes were sealed with
a silicon stopper under a N2 atmosphere and freeze-thawed
10 times to promote sample homogeneity. Samples with a
higher cholesterol concentration in the bilayer were supple-
mented with undeuterated cholesterol. For peptide-containing
samples, 1 ímol of the indicated peptide was weighed,
dissolved in TFE (0.5 mL), and added to the lipid mixture.
The NMR experiments employing tryptophan-deuterated
WALP peptides were performed on oriented samples. Stock
solutions of deuterated WALP peptides were prepared with
a concentration of ca. 500 íM in TFE. For each oriented
sample, typically 2 ímol of deuterated peptide and 50 ímol
of phospholipids were mixed in solution. For samples also
containing cholesterol, 2 ímol of the sterol was added to
the mixture. Organic solvents were removed as described
above, and the sample was redissolved in a mixture of
methanol and chloroform (1/1, v/v, 2 mL). This mixture was
distributed over 50 glass platelets (4.8 mm  23 mm 
0.06-0.08 mm; Marienfeld Laboratory Glassware, Lauda-
Ko¨nigshafen, Germany), and solvents were evaporated as
described. Then the platelets were stacked into a square glass
cuvette and if necessary supplemented with empty glass
platelets to ensure a tight fit. The sample was hydrated with
deuterium-depleted water to 40% (w/w) hydration, and the
cuvette was sealed immediately under a nitrogen atmosphere
using a glass plate and quick-drying epoxy glue. To promote
alignment of the bilayers along the glass plates, the samples
were incubated at 37 °C for at least 3 days before NMR
measurements.
NMR experiments were carried out on a Bruker Avance
500 MHz wide bore spectrometer (Bruker Biospin, Karlsru-
he, Germany). All NMR measurements were performed at
40 °C. The samples were allowed to equilibrate for at least
10 min before measurements. The bilayer alignment of the
oriented samples was checked by 31P NMR experiments as
described in ref 36. 2H NMR experiments were performed
at 76.78 MHz using a quadrupolar echo sequence (37), an
echo delay of 50 ís, and a relaxation time of 100 ms. For
2H NMR measurements on the samples containing deuterated
cholesterol, 400 000 scans were acquired. For the oriented
samples containing deuterated peptides, 2.4  106 and 1.6
 106 scans were acquired for the 0° and 90° orientations
of the bilayer normal to the magnetic field, respectively.
RESULTS
FRET Experiments. FRET measurements were carried out
to obtain information about the lateral distribution of sterols
in the bilayer in the presence of tryptophan-flanked peptides.
Since cholesterol itself is not fluorescent, we used the
fluorescent cholesterol analogue DHE. The fluorescence
characteristics of WALP23 and DHE in bilayers of DMPC
are shown in Figure 1. The emission of the tryptophans (solid
line) overlaps with the absorbance of DHE (dashed line) in
the range of 300-355 nm which allows FRET between these
molecules, whereby the tryptophans of WALP23 serve as
Ftrans(t) ) exp(-2ðw2n s0w/(w2+Re2)1/2 
{1 - exp[-(R0Re)6( t〈ô〉)R6]}R-3 dR) (3)
iDA(t) ) iD(t)Fcis(t)Ftrans(t) (4)
E ) 1 -
s0∞iD(t)Fcis(t)Ftrans(t) dt
〈ô〉D
(5)
FIGURE 1: Spectral overlap for the FRET pair with WALP23 as
the donor and DHE as the acceptor in LUVs of DMPC at pH 7.0:
(- - -) absorption spectrum of DHE with a molar absorption
coefficient  of 7300 M-1 cm-1 at maximal absorption at 324 nm,
(s) fluorescence emission spectrum of WALP23, and (âââ) fluo-
rescence emission spectrum of DHE. The spectra were recorded at
a temperature of 30 °C. The excitation wavelength was 280 nm
for WALP23 and 324 nm for DHE.
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the donor and DHE serves as the acceptor. For DHE, the
maximal molar extinction coefficient in DMPC bilayers was
determined to be 7300 M-1 cm-1 at 324 nm by comparison
with absorption of DHE in methanol using a molar extinction
coefficient of 10 500 M-1 cm-1 at 324 nm (25). The overlap
integral was solved on the basis of the absorption spectrum
of DHE and the normalized emission spectrum of WALP23
as shown in Figure 1. The quantum yield of the tryptophans
of WALP23 in DMPC bilayers was determined to be 0.106
using tryptophan in water as a standard (30) and an excitation
wavelength of 280 nm. On the basis of these parameters,
the characteristic Fo¨rster distance for the FRET pair,
WALP23 and DHE, was calculated to be 20 Å according to
eq 1.
Distribution of Cholesterol in the Membrane. Steady-state
fluorescence spectra were recorded on DMPC bilayers
containing WALP23 peptides and increasing concentrations
of 0-8 mol % DHE in the lipid fraction (Figure 2A). From
the spectral line shapes, it is clear that as the surface density
of DHE in the bilayer increases, the intensity of the emission
due to the tryptophans of WALP23 (dashed lines in the top
panel) decreases. A concomitant increase in the emission of
the acceptor is observed (solid lines in the bottom panel),
which is mainly the sensitized emission of DHE (due to
FRET from WALP23) and a minor contribution of the direct
excitation of DHE at 280 nm. Because the emission spectra
of WALP23 and DHE overlap to a great extent (see Figure
1), the recorded spectra need to be decomposed into the
emission of the donor and the emission of the acceptor to
calculate the FRET efficiency from the integrated area of
the spectrum. In principle, the calculation could also be
performed from the steady-state intensity at a given wave-
length at which there is no emission from the acceptor.
However, via decomposition of the spectra, it is possible to
check whether the shape of the emission spectra remains the
same, ruling out the presence of other photophysical pro-
cesses. In addition, the method is more reliable since the
area under the spectrum is directly proportional to the
quantum yield of fluorescence even if small spectral shifts
are taking place. Since the emission between 300 and 330
nm originates exclusively from the tryptophans of WALP23,
we fitted the emission spectrum of WALP23 in the absence
of acceptor DHE in the range between 300 and 330 nm to
the emission spectra for different concentrations of DHE.
The FRET efficiency was then calculated from the area
integral ratio between the fitted spectrum and the original
spectrum for donor only as E ) 1 - DA/D, where  is the
quantum yield of the donor alone (D) or in the presence of
acceptor (DA). Subtraction of the fitted spectrum from the
total emission spectrum yielded the emission of DHE (Figure
2B).
The FRET efficiencies are plotted in Figure 3 (O) as a
function of the surface density of DHE in the bilayer which
was calculated from the mole fraction of DHE in the bilayer
using areas per lipid molecule of 59.5 Å2 for DMPC (38)
and 37.7 Å2 for DHE and cholesterol (39). Condensation
effects due to sterols present in the bilayer were assumed to
be negligible at the low concentrations of sterols used here
(39). The FRET efficiency in a bilayer, a quasi-two-
dimensional system, depends on the Fo¨rster distance of the
FRET pair, the exclusion radius of the acceptor around the
donor, and the amount and distribution of acceptor in the
bilayer. The theoretical FRET efficiency for a random
distribution of WALP23 and DHE in both leaflets of the
bilayer was calculated on the basis of eqs 2 and 3 computed
into eq 5. This curve is shown in Figure 3 (s) for different
theoretical values of the Fo¨rster distance. The experimentally
determined FRET efficiencies for different surface densities
of DHE match the theoretical FRET efficiency curve for the
calculated Fo¨rster distance of 20 Å (O in Figure 3). If the
acceptor were excluded from the vicinity of the donor, the
experimental FRET efficiencies would be located below the
theoretical FRET efficiency curve (see ref 40 for a nonho-
mogeneous distribution with acceptor excluded from donor).
FIGURE 2: Fluorescence emission spectra of WALP23 and of DHE in bilayers of DMPC containing different concentrations of sterols at
pH 7.0 and 30 °C. (A) The solid lines are spectra from FRET experiments using increasing DHE concentrations (from top to bottom, 0,
0.25, 0.5, 1, 2, 4, and 8 mol %) added to the lipid fraction. The dashed lines show the fluorescence emission of the tryptophans of WALP23,
obtained by decomposition. (B) Fluorescence emission of DHE (from top to bottom, 8, 4, 2, 1, 0.5, and 0.25 mol %), obtained by decomposition
of the spectra in panel A. (C) Samples as in panel A but with equimolar amounts of DHE and cholesterol added to the lipid fraction. (D)
Fluorescence emission of DHE in the presence of equimolar amounts of cholesterol, obtained by decomposition of the spectra in panel C.
In all samples, the excitation wavelength was 280 nm and the final concentration of WALP23 was 5 íM using a peptide/lipid ratio of
1/200.
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Alternatively, if the acceptor is attracted to the donor, the
experimental values would be located above the theoretical
curve. Therefore, these results indicate that DHE is randomly
distributed in the bilayer in the presence of tryptophan-
flanked peptides.
As a complementary approach, we also used time-resolved
fluorescence techniques (41). Fluorescence decays were
recorded for the same sample compositions used for the
steady-state measurements described above (Figure 4 A).
With an increasing DHE concentration in the lipid bilayer,
the intensity of tryptophan fluorescence is decaying faster
due to an increasing level of FRET from the tryptophans to
DHE. The fluorescence decay of WALP23 in DMPC at 30
°C shows multiexponential behavior and can be described
by a sum of three exponentials with the following param-
eters: ô1 ) 0.31 ns (28%), ô2 ) 1.72 ns (39%), and ô3 )
5.24 ns (33%) (corresponding to an average lifetime of 4.12
ns). Both the average lifetime and the lifetime components
are very similar to those obtained for the tryptophan-flanked
çM4 peptide, an R-helical transmembrane segment of the
nicotinic acetylcholine receptor (40, 42).
In a global analysis approach, the decay curves for
different concentrations of DHE (shown in Figure 4A) were
fitted simultaneously on the basis of a FRET model for a
single discrete concentration of acceptors according to eq 4.
With the exception of the varying acceptor density n, all other
parameters (R0, Re, 〈ô〉, and w) were linked in the global
analysis and therefore forced to have identical values for all
decays, i.e., the same values as for the integrated curve with
an R0 of 20 Å shown in Figure 3. Good quality fits from
global analysis are characterized by a low global łG2, which
is indicative of a good agreement with the underlying model
of a random distribution of acceptor molecules in the bilayer.
The global analysis of the decay series for bilayers containing
WALP23 and different concentrations of DHE yielded a low
łG2 of 1.43 which indicates a homogeneous distribution of
the acceptor DHE in the bilayer (compare to ref 42). This
result confirms the findings from steady-state fluorescence
experiments.
Since the complex ring system of DHE has a three-
dimensional shape different from that of cholesterol, it is in
principle possible that cholesterol, but not DHE, interacts
preferentially with the tryptophan-flanked peptide. This
question was addressed by a competition experiment where
also cholesterol is present in the bilayer. If cholesterol would
also be randomly distributed in the bilayer, the FRET
efficiency should stay unchanged, whereas if cholesterol is
attracted toward the tryptophans, it pushes the acceptor DHE
away from the tryptophans and lowers the effective acceptor
surface density in the vicinity of the donor, which in turn
lowers the FRET efficiency (see Figure 5).
Steady-state fluorescence spectra were recorded for samples
containing equimolar concentrations of DHE and cholesterol
in the lipid fraction (Figure 2C), and the spectra were
analyzed as described above. The results show that also in
the presence of cholesterol the experimentally determined
FRET efficiencies match the theoretical FRET efficiency
curve for the Fo¨rster distance of WALP23 and DHE (4 in
Figure 3). Thus, the competition experiments indicate a
random distribution of cholesterol in the bilayer. This was
supported by fluorescence decay measurements on samples
containing equimolar amounts of DHE and cholesterol in
the lipid fraction (Figure 4B). There is no significant change
FIGURE 3: Theoretically calculated FRET effciency curves (eq 5)
for different Fo¨rster distances based on the model for a random
distribution of acceptor taking into account transfer two both leaflets
(eqs 2 and 3) are shown as solid lines. FRET effciencies calculated
from steady-state data (Figure 2) with WALP23 as the donor and
DHE as the acceptor depending on the surface density of the
acceptor in the bilayer in the presence of only DHE (O) and in the
presence of the equimolar amounts of DHE and cholesterol (4).
FIGURE 4: Fluorescence intensity decays of WALP23 in the presence of varying concentrations of DHE in bilayers of DMPC at pH 7.0 and
30 °C. The bilayers contained either no cholesterol (A) or equimolar amounts of cholesterol (B). Global analysis of the data according to
the model for a random distribution of DHE (eqs 2 and 3) resulted in the fitting curves shown yielding global łG2 values of 1.43 for panel
A and 1.35 for panel B.
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in decay behavior if cholesterol is also added to the bilayer
compared to bilayers containing only DHE (Figure 4A).
Global analysis of the decay series for different equimolar
concentrations of DHE and cholesterol yielded a łG2 of 1.35,
indicating a good agreement with the underlying model of
random distribution of DHE (and therefore also of choles-
terol) in the bilayer which strongly supports the finding of a
random distribution of both DHE and cholesterol in the
bilayer.
2H NMR Results. All results obtained from fluorescence
experiments indicate a random distribution of cholesterol in
the bilayer in the presence of tryptophan-flanked peptides.
Nevertheless, it is still possible that specific interactions occur
between cholesterol and interfacial tryptophans which could
influence the behavior of these molecules and thereby
influence the properties of the membrane. Such an interaction
could also be mediated via neighboring lipids. To investigate
these possibilities, we performed 2H NMR experiments on
samples containing either deuterated cholesterol or tryp-
tophan-deuterated WALP peptides. 2H NMR spectroscopy
is a very sensitive tool for observing small changes in
dynamics and/or orientational properties of molecules and
does not rely on the use of a fluorescent cholesterol analogue.
Any change in orientation and/or dynamics of labeled
molecules leads to a change in 2H NMR spectra since the
average orientation of the C-D bonds with respect to the
magnetic field is altered. 2H NMR experiments can also be
used to detect different populations of molecules that may
occur if only parts of the population are influenced by
specific interactions with other molecules. We investigated
both the effect of WALP23 on deuterated cholesterol and
the effect of cholesterol on tryptophan-deuterated WALP23.
Influence of Tryptophan-Flanked Peptides on Deuterated
Cholesterol. For the 2H NMR measurements, we used â-(d6-
2,2,3,4,4,6)cholesterol which has deuterons located near the
hydroxyl headgroup. To investigate the influence of WALP23
peptides on deuterated cholesterol, we incorporated 2 or 4
mol % cholesterol into unoriented DMPC bilayers and
compared the spectra in the presence and absence of 1 mol
% tryptophan-flanked WALP23 peptide. To distinguish
effects due to the presence of interfacial tryptophans from
effects due to the incorporation of peptides into the cholesterol-
containing bilayers, we used the lysine-flanked KALP23
peptide as a control peptide. At first glance, the 2H NMR
spectra of all these samples (shown in Figure 6) look very
similar, indicating that there are no large effects on the
orientation and dynamics of cholesterol. However, some
subtle but significant changes in the values of the quadrupolar
splittings occur which will be discussed later.
The 2H NMR spectrum for a bilayer containing 2 mol %
deuterated cholesterol in the absence of peptide (top row in
Figure 6) is typical for â-(d6-2,2,3,4,4,6)cholesterol incor-
porated into fluid phase bilayers (43). Knowing that the
orientation of cholesterol in the bilayer is rather fixed along
its long axis, the similarity of the 2H NMR spectra suggests
the same assignment of the splittings to the deuterons in all
cases which allows direct comparison of the quadrupolar
splittings summarized in Table 2.
Closer inspection of the quadrupolar splittings in the
absence of peptides shows that addition of more cholesterol
(4 mol %) leads to a small increase of 0.6-0.8 kHz in
quadrupolar splittings. Cholesterol is known to straighten the
acyl chains of surrounding lipids which leads to a condensa-
tion effect on the membrane bilayer. This affects the
dynamics of cholesterol itself which leads to the larger
quadrupolar splittings (43). This observation demonstrates
that 2H NMR spectroscopy employing deuterated cholesterol
is a sensitive tool for observing very small changes in the
behavior of cholesterol.
The presence of WALP23 peptides in the bilayer leads to
a small but significant increase of 0.4-0.6 kHz in the
quadrupolar splittings at both cholesterol concentrations that
were used. Control experiments using 1 mol % KALP23
show no significant increase in the quadrupolar splittings in
the presence of a lysine-flanked peptide. This could suggest
an interaction between cholesterol and tryptophan. However,
it was shown before that WALP23 also has a stretching effect
FIGURE 5: Schematic top view of the membrane illustrating two
possible outcomes for the competition experiment using bilayers
containing DHE and cholesterol. (A) Both DHE (gray circles) and
cholesterol (black circles) are randomly distributed which leaves
the FRET effciency unchanged when compared to that from the
experiment in the absence of cholesterol. (B) Cholesterol occupies
the sites next to the tryptophans of WALP23 and pushes in turn
DHE away which leads to a lower FRET effciency.
FIGURE 6: 2H NMR spectra of â-(d6-2,2,3,4,4,6)cholesterol in
unoriented bilayers of DMPC at pH 7.0 and 40 °C in the absence
and presence of KALP23 or WALP23. The quadrupolar splittings
can be assigned to the deuterons in â(d6-2,2,3,4,4,6)cholesterol
starting from outside: (3), (2,4)ax, (2,4)eq; position (6) is hidden in
the central isotropic peak (43, 57).
Table 2: Quadrupolar Splittings from 2H NMR Spectra of
Unoriented Samples Containing Deuterated Cholesterol
quadrupolar splittings (kHz)
peptide cholesterol (mol %) (3) (2,4)ax (2,4)eq
- 2 40.4 37.4 25.2
4 41.2 38.1 25.8
WALP23 2 41.0 38.0 25.6
4 41.8 38.7 26.2
KALP23 2 40.4 37.5 25.2
4 41.3 38.3 25.9
WLP23 2 42.3 39.4 26.5
KLP23 2 40.7 37.8 25.4
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on the bilayer similar to that of cholesterol (18) which could
cause an increase in quadrupolar splittings. Therefore, the
increase in quadrupolar splittings could also be due to the
membrane stretching effect of WALP23.
To discriminate between these possibilities, we investi-
gated how membrane stretching due to the presence of
peptides in the membrane influences the quadrupolar split-
tings. For this purpose, we used WLP23 and KLP23 which
have the same length as WALP23 and KALP23 but have a
more hydrophobic stretch of only leucines. Previously, it was
found that a lysine-flanked transmembrane peptide having
a hydrophobic core of polyleucines exerts a stronger ordering
effect on lipid acyl chains than an analogous peptide with a
core of alternating leucines and alanines (44). Preliminary
experiments in our laboratory indicated that this is also the
case for WLP23 and KLP23. If membrane stretching due to
the peptides in the bilayer would be the only factor
responsible for the increase in quadrupolar splittings of
deuterated cholesterol, then we should expect an increase in
the quadrupolar splittings for WLP23 compared to WALP23
and for KLP23 compared to KALP23. Evaluation of the
quadrupolar splittings for WLP23 and KLP23 listed in Table
2 (2H NMR spectra not shown) shows that the presence of
the polyleucine peptides in the membrane indeed leads to a
significant increase in the quadrupolar splittings as compared
to those of the leucine-alanine peptides. Thus, the difference
in the quadrupolar splittings in the presence of WALP23 and
KALP23 in the bilayer can most likely be attributed to
differences in the stretching effect of the peptides.
It is important to note that all 2H NMR spectra compared
show only one component upon addition of WALP23
peptides to the bilayer. This absence of a second component
points toward one major population of cholesterol in the
bilayer. Therefore, the 2H NMR experiments using deuterated
cholesterol provide no indication for an effect on the
dynamics and/or orientation of cholesterol caused by an
interaction with interfacial tryptophans.
Influence of Cholesterol on Deuterated Tryptophan Side
Chains. Next, in a complementary approach, we investigated
whether the presence of cholesterol changes the orientation
and/or dynamics of the interfacial tryptophans. We performed
2H NMR experiments using tryptophan-deuterated WALP23
peptides. The peptides were synthesized with tryptophans
containing a deuterated indole ring in one position at a time
(for amino acid sequences, see Table 1). Oriented samples
with a peptide/lipid ratio of 1/25 containing either no
or 4 mol % cholesterol in the lipid fraction were prepared.
31P NMR measurements on all oriented samples confirmed
a good alignment of the bilayers along the glass platelets
(31P NMR spectra not shown). The 2H NMR spectra of
samples containing WALP23-d5-Trp2 and WALP23-d5-Trp3
in the presence and absence of cholesterol are shown in
Figure 7. The measurements were performed at two different
orientations of the bilayers: at 0° with the membrane normal
aligned to the magnetic field and at 90° with the membrane
normal perpendicular to the magnetic field.
The deuterated indole ring contains five deuterons where
two deuterons (positions 4 and 7) are equivalent in view of
the geometry of the indole ring and therefore bear the same
quadrupolar splitting (21). Thus, four quadrupolar splittings
are expected for WALP23 with indole ring-deuterated
tryptophans. Previous 2H NMR experiments on oriented
samples containing the tryptophan-flanked gramicidin A (21,
45, 46) or WALP peptides (47, 48) showed that not all
splittings are always detected for either orientation of the
bilayers with respect to the magnetic field. Looking at the
2H NMR spectra for WALP23-d5-Trp2, we can distinguish
four splittings for the 90° orientation (Figure 7A, right
column) compared to only three splittings for the 0°
orientation (Figure 7A, left column). The size of the
quadrupolar splittings in the 90° orientation can be expected
to be halved compared to the 0° orientation due to the fast
axial reorientation of the peptides about the bilayer normal
(36). Comparison of the values for WALP23-d5-Trp2 in
Table 3 shows that this is indeed the case. From these values,
it can furthermore be concluded that the largest splitting in
the 0° orientation is not detected. This is probably due to
insufficient sensitivity caused by the magnitude of the
quadrupolar splittings in combination with the relatively low
peptide/lipid ratio.
The assignments of the quadrupolar splittings to the
deuterons of the indole ring cannot be done unambiguously
without further experiments, e.g., 2H NMR experiments with
FIGURE 7: 2H NMR spectra of WALP23-d5-Trp2 (A) and WALP23-
d5-Trp3 (B) in oriented bilayers of DMPC at pH 7.0 in the absence
and presence of 4 mol % cholesterol added to the lipid fraction at
40% (w/w) hydration and measured at 40 °C.
Table 3: Quadrupolar Splittings from 2H NMR Spectra of Oriented
Samples Containing WALP23-d5-Trp2 in the Absence and Presence
of Cholesterol
cholesterol (mol %) quadrupolar splittingsa (kHz)
0° - 18 38 57 -
90° - 9 19 29 41
0° 4 15 40 60 -
90° 4 6 20 30 39
a The quadrupolar splittings are estimated to have an experimental
error of 1-2 kHz (compare to ref 48).
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partly deuterated indole rings (21) or NMR experiments
employing other labels. Nevertheless, the quadrupolar split-
tings can be considered as fingerprints for the orientational
and motional properties of the tryptophan side chains. The
shape of the 2H NMR spectrum of WALP23-d5-Trp2 does
not change upon addition of cholesterol (compare the top
and bottom rows of Figure 7A), and there is no significant
increase or decrease in the visible quadrupolar splittings (see
Table 3). For WALP23-d5-Trp3, it is more difficult to
distinguish (all) the quadrupolar splittings (data not listed),
but also for this peptide, the same findings hold (Figure 7B).
The results therefore suggest that the orientation and dynam-
ics of the indole rings are not influenced by cholesterol (on
the 2H NMR time scale). Hence, these experiments also
indicate that there is no specific interaction between cho-
lesterol and interfacial tryptophans.
DISCUSSION
The main objective of this study was to investigate how
cholesterol and interfacial tryptophans of transmembrane
peptides or proteins interact in a bilayer and what the possible
consequences are for the organization and distribution of
these molecules in membranes. For our study, we chose a
well-defined model system of tryptophan-flanked transmem-
brane peptides incorporated into cholesterol-containing bi-
layers, sampling a biologically relevant system for such an
interaction. To gain insight into the interaction between
cholesterol and interfacial tryptophans, we employed a 2-fold
approach, including FRET experiments and solid-state 2H
NMR measurements.
Choice for a Low Cholesterol Concentration in the Bilayer.
All experiments were performed on bilayers containing only
small amounts of cholesterol in the lipid fraction. One reason
for this was the consideration that if indeed preferential
interactions would occur, they would most easily be observed
at low cholesterol concentrations where random contacts
between the peptide and the sterol are only few in number.
Even more important, however, was the consideration that
a low cholesterol content is essential to ensure a homoge-
neous system. It is well-known that higher cholesterol
concentrations in a phospholipid bilayer can lead to the
formation of coexistent phases in the bilayer (49, 50). The
onset of phase separation into liquid-ordered (Lo) and liquid-
disordered (Ld) domains is strongly dependent on temperature
and cholesterol content. For the two-component system used
in this study (DMPC/cholesterol), at 30 °C the phase
separation starts at 8 mol % cholesterol in the bilayer and at
40 °C at 14 mol % cholesterol (51), generating a laterally
heterogeneous composition of the bilayer. The liquid-ordered
domains contain a higher cholesterol concentration and have
an increased membrane thickness compared to the liquid-
disordered domains. The resulting heterogeneous system
would complicate, if not prohibit, the interpretation of the
experimental data.
This holds in particular for the FRET experiments where
data analysis is based on the comparison of experimental
FRET efficiencies with theoretical FRET efficiencies where
the values are calculated on the basis of a random distribution
of donor and acceptor in the bilayer. In the case of a phase
separation in the bilayer, more cumbersome models would
have to be used, which would have to account, among other
complexities, for the partitioning of both peptide and DHE
between the different phases (41). For these various reasons,
we decided to use only small cholesterol concentrations of
<8 mol % cholesterol in DMPC bilayers for our experiments.
Cholesterol Does Not Preferentially Localize Next to
Tryptophan-Flanked Peptides. In case of a preferential
interaction with interfacial tryptophans, one would expect a
nonrandom distribution of cholesterol in the bilayer when a
tryptophan-flanked peptide is included. The sterol would be
preferentially localized in the vicinity of the peptide and
hence would be depleted from the bulk lipid. To analyze
the distribution of cholesterol in the bilayer, FRET experi-
ments were performed in which we used the tryptophans of
the WALP23 peptides as the donor and the fluorescent
cholesterol analogue DHE as the acceptor. We found that
DHE is randomly distributed in the presence of interfacial
tryptophans, suggesting that there is no preferential interac-
tion between DHE and interfacial tryptophans.
In these experiments, DHE was used because cholesterol
does not possess a chromophore with absorption overlapping
the emission of tryptophan and because DHE was shown to
be suitable for investigation of sterol behavior in the
membrane (25). Similar studies employing the cholesterol
analogue DHE as the acceptor for FRET experiments have
been conducted with, for example, melittin (52) and the çM4
segment of the nicotinic acetylcholine receptor (AChR) (40).
Although cholestatrienol, another fluorescent cholesterol
analogue, mimics the properties of cholesterol in the
membrane better (53), this analogue has some disadvantages
compared to DHE. It degrades rapidly and requires diligent
sample handling (54). With regard to the special properties
of cholesterol in the membrane, both analogues do mimic
cholesterol only to a limited extent and have poorer
condensation effects on the bilayer (53, 55). This emerges
from two extra double bonds in the complex ring structure
of DHE and cholestatrienol, which cause the fluorescent
character but also change the three-dimensional shape of the
analogues in comparison to that of cholesterol.
In principle, it is possible that the difference in three-
dimensional structure between DHE and cholesterol could
change the behavior with respect to a possible (stacking)
interaction with interfacial tryptophans. To gain information
about the distribution of cholesterol itself in bilayers contain-
ing tryptophan-flanked peptides, we performed a competition
experiment in which both the fluorescent cholesterol ana-
logue DHE and cholesterol were incorporated into the
bilayers at the same concentration. Cholesterol was found
not to compete with DHE for sites next to the tryptophans
which strongly suggests that cholesterol is randomly dis-
tributed in the bilayer. This finding points toward no
preferential interaction between cholesterol and interfacial
tryptophans, suggesting that it is equally favorable for
cholesterol to be adjacent to WALP23 peptides as it is to be
in contact with the lipid acyl chains.
Cholesterol and Interfacial Tryptophans Do Not Affect
Each Other’s Orientation and/or Dynamics. Even for a
random distribution of cholesterol in the bilayer it is still
possible that cholesterol and interfacial tryptophans affect
each other in a specific way, possibly mediated by adjacent
lipids. Since any interaction between two molecules is
associated with changes in the dynamics and/or orientation
of the molecules involved, we used solid-state 2H NMR
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spectroscopy to test this hypothesis. This technique is a sensi-
tive tool for observing small changes in dynamics and/or
orientation of deuterium-labeled compounds in a lipid bilayer.
We performed 2H NMR measurements employing either
deuterated cholesterol or tryptophan-deuterated WALP23
peptides. We found that the magnitudes of the quadrupolar
splittings yielded by the deuterated tryptophans do not change
after addition of cholesterol to the bilayer. In the case of
deuterated cholesterol, small changes in the sizes of the qua-
drupolar splittings were observed which could be attributed
to small differences in the effects of the peptides on lipid
chain order in the bilayer. These findings suggest that there
is no change in the average orientation or in dynamics for
either cholesterol or the tryptophan side chains of WALP23
and therefore that these molecules have neither a direct nor
a lipid-mediated influence on each other. Another important
observation was that for all 2H NMR spectra recorded in
the presence of either deuterated cholesterol or deuterated
tryptophan-flanked peptides in the bilayer, only one com-
ponent could be distinguished. This absence of a second
population is another indication of the absence of specific
interactions resulting in preferential surrounding of the
peptide by cholesterol. Hence, these findings are in good
agreement with the results from the FRET experiments.
Nature of Interaction between Cholesterol and Interfacial
Tryptophans. Via examination of the molecular structures
of cholesterol and tryptophan, it is very well conceivable
that the complex ring structure of cholesterol directly interacts
with the tryptophan indole ring. Indeed, molecular modeling
studies suggested favorable stacking interactions between
cholesterol and tryptophan where the face of the complex
ring system of cholesterol and the indole ring of tryptophan
build the interaction interface (personal communication with
R. Brasseur, CBMN, Gembloux, Belgium). In a phospholipid
bilayer, the long axis and therefore also the flat face of the
complex ring system of cholesterol are oriented almost
parallel to the bilayer normal (56, 57). It is possible to
calculate the orientation of the tryptophan side chain with
respect to the bilayer from the quadrupolar splittings of a
deuterated indole ring if the spectral assignments are known
(21, 46).
Preliminary attempts to calculate the orientations of the
deuterated tryptophans of WALP23-d5-Trp2 and WALP23-
d5-Trp3 using an automatic assignment procedure yielded
for both tryptophan positions a reliable minimum for a single
orientation. The best fits to the sets of quadrupolar splittings
summarized in Table 3 yielded very similar orientations both
in the absence and in the presence of cholesterol in the
bilayer. For both WALP23-d5-Trp2 and WALP23-d5-Trp3,
the flat face of the tryptophan indole ring adopts an angle
of approximately 30° with respect to the bilayer normal
which is comparable to the orientations determined for the
tryptophan side chains in gramicidin A (21). Such an
orientation of the tryptophan indole ring would imply that
for a stacking interaction either the indole ring or the
cholesterol would need to turn 30° with respect to the
bilayer normal. 2H NMR experiments clearly show that the
orientations of both the indole ring and cholesterol remain
unchanged in the presence of the respective other molecule
in the bilayer. In view of these considerations, this suggests
that no direct stacking interaction occurs between tryptophan
and cholesterol.
In general, two molecules will preferentially interact if this
interaction leads to a decrease in the free energy of the
system. Apparently, the energy cost for changing the
orientation of interfacial tryptophans and/or cholesterol to
facilitate a preferential interaction in combination with the
loss of entropy resulting from such an interaction is higher
than the energy gain from a specific interaction between the
two molecules. By itself, this is not surprising. The orienta-
tion of cholesterol in the bilayer is governed by its am-
phiphilic properties whereby the small hydroxyl headgroup
of cholesterol preferably resides between the phospholipid
headgroups. A change in the orientation of cholesterol, e.g.,
of 30° with respect to the bilayer normal, can be expected
to result in a large energy cost due to its preferable alignment
alongside the lipid acyl chains. The side chain of tryptophan
is small compared to cholesterol, but it is connected to a
larger peptide backbone, which restricts the number of
possible and energetically favorable orientations. Statistical
analysis of side chain conformations in R-helices of known
structures of (membrane) proteins shows that only certain
combinations of  and ª torsion angles for tryptophans are
feasible and favorable (58, 59). These constraints may
prevent a preferential interaction between tryptophans and
cholesterol in the bilayer.
The results of this study seem in contradiction with all
earlier indications found for a specific interaction between
cholesterol and tryptophans located in the bilayer. How can
we explain this? It is important to note here that all
experiments indicating such a preferential interaction were
carried out in bilayer systems with a relatively high
cholesterol content. Either the protein resides in a membrane
that (natively) has a very high cholesterol content, as is the
case of the acetylcholine receptor-enriched membranes from
the neuro-muscular junction (14), or the membrane contains
cholesterol-rich domains, as for caveolae (13) or lipid rafts
(1), into which the protein partitions favorably. High
cholesterol concentrations in a bilayer change the behavior
of the cholesterol in the bilayer itself as well as the material
properties of the bilayers compared to a bilayer containing
no or only low concentrations of cholesterol (60). Thus, it
is possible that the two situations may not be comparable
and that our findings may not be applicable to proteins in
caveolae and rafts. Furthermore, in the case in which a
tryptophan-containing peptide or protein is present in a
cholesterol-rich environment, this will increase the prob-
ability for their interaction. Together with the changed bilayer
properties, this may result in a modulation of membrane and
protein structure and dynamics which in the studies men-
tioned above has been thought to possibly involve a
preferential interaction between cholesterol and tryptophans.
The suggested specificity for cholesterol and tryptophan
in these studies may also be related to the anchoring
properties of tryptophans in membrane proteins. Previously,
it has been observed that tryptophans are preferably located
in the lipid-water interface (7, 9, 61). Higher cholesterol
concentrations are known to lead to a laterally heterogeneous
bilayer containing cholesterol-enriched domains which have
an increased thickness compared to the cholesterol-depleted
domains. Depending on its hydrophobic length, the peptide
or protein can be driven toward the thicker and thus
cholesterol-enriched domains of the bilayer to relieve the
hydrophobic mismatch. Since tryptophans have been shown
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to be essential for the proper positioning of proteins in
(biological) membranes (62-65), a mutation in this residue
may place it out of cholesterol-rich domains even when there
is no specific interaction between cholesterol and interfacial
tryptophans. Hence, there would be only an apparent
specificity.
In any case, our study on model systems with relatively
low cholesterol concentrations has clearly demonstrated that
cholesterol and tryptophan do not have a general tendency
to preferentially interact with one another. This is an
important result, because it improves our understanding of
the basic principles behind the organization of proteins and
lipids in membranes, here in particular between interfacial
tryptophans abundant in membrane proteins and cholesterol,
a membrane constituent in many types of biological mem-
branes.
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